Global Artemisinin Market Growth 2025-2031

Global Artemisinin Market Growth 2025-2031

The global Artemisinin market size is predicted to grow from US$ 87.1 million in 2025 to US$ 270 million in 2031; it is expected to grow at a CAGR of 20.7% from 2025 to 2031.

Artemisinin is a natural compound extracted from the sweet wormwood plant (Artemisia annua), widely recognized for its potent antimalarial properties. It is effective in rapidly reducing malaria parasite levels in the blood and is a primary component of artemisinin-based combination therapies (ACTs), which are the standard treatment for malaria worldwide. Due to its effectiveness and rapid action, artemisinin has been a critical advancement in global malaria control efforts.

The artemisinin market is driven primarily by the global need to combat malaria, a disease that affects millions, especially in tropical and subtropical regions. As a key ingredient in artemisinin-based combination therapies (ACTs), the standard treatment for malaria, demand for artemisinin remains strong, especially in regions with high malaria prevalence. Increasing global health initiatives and funding from governments and organizations like the World Health Organization (WHO) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria continue to support artemisinin production and distribution. Additionally, advancements in synthetic biology and semi-synthetic production methods are helping to stabilize supply.

The artemisinin market faces challenges such as dependency on seasonal agricultural production from Artemisia annua, which can lead to fluctuations in supply and pricing. Climate variability and agricultural risks can impact the availability and quality of raw material, causing potential shortages. Additionally, resistance to artemisinin is emerging in some regions, particularly in Southeast Asia, raising concerns over the long-term efficacy of artemisinin-based therapies. This resistance is pushing researchers and health organizations to seek alternative treatments, which may impact future demand for artemisinin.

LP Information, Inc. (LPI) ' newest research report, the “Artemisinin Industry Forecast” looks at past sales and reviews total world Artemisinin sales in 2024, providing a comprehensive analysis by region and market sector of projected Artemisinin sales for 2025 through 2031. With Artemisinin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin industry.

This Insight Report provides a comprehensive analysis of the global Artemisinin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artemisinin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin.

This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Extraction From Artemisia Annua
Semisynthetic Artemisinin

Segmentation by Application:
Antimalarial Injections
Antimalarial Tablets

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Fosun Group
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Huafang Ketai
Huali Phamra

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artemisinin market?

What factors are driving Artemisinin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artemisinin market opportunities vary by end market size?

How does Artemisinin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.